A brief the essence in brief and basics

Principal active substance: cyclobenzaprine, sometimes marketed elsewhere under the brand name Flexeril.

Mechanism: Cyclobenzaprine is a centrally acting muscle relaxant. It reduces the perception of muscle spasm and associated discomfort by altering neural signals in the central nervous system rather than by a direct effect on skeletal muscle fibers.

Formulations commonly available in countries where it is licensed include immediate-release tablets (5 mg and 10 mg) and in some places an extended-release 15 mg tablet. Note that cyclobenzaprine is not routinely licensed in the UK; see UK statutory framework for access guidelines and rules for how it may be obtained and for regulatory considerations.

While it is being used

Clinicians usually recommend cyclobenzaprine for short-term symptomatic relief of acute muscle spasm after soft tissue injuries such as sprains, strains or sudden muscle overuse. It is intended as an adjunct to conservative measures like rest, physiotherapy, graduated exercise and local heat or cold application.

Longer courses are generally avoided because long-term benefits are limited as well as the risk of undesired consequences rises with continued treatment. Typical recommended duration is a few weeks only.

How to take a stand

Typical course duration: Most prescribers advise limiting treatment to two or three weeks. Always follow the dosage guidelines provided by your prescriber and also the leaflet supplied with the medicine.

Starting and adjusting dose: Prescribers often start at a lower dose and step up if required and tolerated. Do not alter your dose or dosing schedule without medical directional guidance.

To learn about handling i skipped one dosesverify this. the information leaflet. What to do if you miss a dose, and for questions about stopping the drug talk to your prescriber.

General safety cautions and cautions

Tell the clinician about any current or past medical conditions, particularly:

• Chronic liver disease or known hepatic impairment
• Glaucoma or history of increased intraocular pressure
• Difficulty passing urine, prostate enlargement or any bladder outlet obstruction
• Known cardiac rhythm problems, coronary artery disease or a recent heart attack

Maternal pregnancy and lactation: Limited safety data exist. If you are pregnant, planning pregnancy or breast-feeding, discuss latent risks and benefits with the prescriber before taking cyclobenzaprine.

Driving and operating machinery: The drug commonly causes drowsiness, dizziness and blurred vision. Avoid alcohol and do not drive or operate heavy machinery until you know how the medicine affects you.

If you are taking antidepressants or other serotonin-affecting drugs, be aware of the risk (though small) of serotonin syndrome. See Secondary effects and emergencies and Adverse coadministration drug to drug the process of interactions in a system describe exchanges between components. for more information, download the information packet.

Who should not be allowed to take it?

Do not start cyclobenzaprine if any of the following apply:

• Known or suspected hyperthyroidism or untreated significant thyroid disease
• Severe cardiac conduction problems, unstable heart failure or recent myocardial infarction
• Current or recent treatment with a monoamine oxidase inhibitor (MAOI) within the previous 14 days

If you are unsure whether these apply to you, consult the prescriber before initiating treatment.

Secondary effects during emergencies

Allergic reactions: Get urgent medical help for signs of a severe allergic response such as widespread rash, swelling of the face, lips or throat, or difficulty breathing.

Stop the medicine and seek emergency attention for serious warning signs including:

• Quick pulse, irregular rhythm, unexplained chest pain
• Sudden weakness, numbness, slurred speech or loss of coordination

Serotonin syndrome: Rare but potentially life threatening. Symptoms may include agitation, confusion or hallucinations; very high temperature and sweating; tremor and muscle stiffness; poor coordination; and severe nausea, vomiting or diarrhea. Call emergency services if these occur.

More common and usually less severe effects include drowsiness, dry mouth, lightheadedness, i am suffering from a headache, nausea and constipation. If residual effects are troublesome or persistent speak to your pharmacist or prescriber.

Adverse medication the exchange between peoples create context for decisions.

Cyclobenzaprine interacts with a range of medicines and may increase sedation or other harmful health effects. Provide a full list of prescription medicines, over-the-counter drugs and herbal products to your clinician and pharmacist.

Medicines that can add to sedation or respiratory depression when combined with cyclobenzaprine include:

• Opioid analgesics, benzodiazepines and other central nervous system depressants
• Certain hypnotics and anxiolytics
• First generation antihistamines commonly found in some cold remedies

Other significant personal people relating to one anothers build trust and rapport. to be aware of:

• MAO inhibitors: coadministration is contraindicated. Allow at least 14 days between stopping an MAOI and starting cyclobenzaprine, and vice versa.
• Serotonergic drugs (some antidepressants, some migraine medicines, St Johns wort supplement): combined use can increase the risk of serotonin syndrome.
• Medications that affect cardiac conduction or have strong anticholinergic effects, and some antibiotics or antivirals that may alter heart rhythm.
• Caution advised with agents such as bupropion, tramadol or meperidine because of risks tied to social interaction.

Missed dose information and guidance

If you forget to take a single dose take it as soon as you remember. If the next scheduled dose is due shortly, skip the not taking the dose and continue with your usual schedule. Do not take a second dose to make up for a not taking the dose.

Overdose syndrome information resource: what to do

If you suspect an overdose case call emergency services immediately. Signs of overdose case can include extreme drowsiness, vomiting, fast heart rate, tremor, severe agitation, hallucinations or loss of consciousness. An overdose case can be serious and requires hospital assessment and supportive care.

Secure handling, stowage and waste disposal

Store the medicine at normal room temperature, commonly between 15 and 30 C, in a closed container away from direct sunlight and out of reach of children. Do not use the product after its expiry date. Return unused or out-of-date medicines to a pharmacy for disposal through an established take-back scheme rather than throwing them away with household waste.

Options and evaluative comparisons

If cyclobenzaprine is not appropriate or not available in the UK, there are several other muscle relaxants and treatment strategies. Choice will depend on the clinical picturepotential energy damaging effects and monitoring needs.

• Baclofen - commonly used for spasticity; can cause drowsiness and dizziness. Withdrawal after long term use should be gradual.
• A medication called Tizanidine - used for spasticity; may lower blood pressure and sometimes requires liver function observation and tracking.
• Methocarbamol - used for acute musculoskeletal spasm; often preferred for short courses and has a lower anticholinergic burden.
• Diazepam - a benzodiazepine with muscle relaxant action; effective short term but carries sedation and dependence risks and is subject to controlled drug regulations.
• Dantrolene - works directly on muscle and is used for chronic spasticity or specific emergencies such as malignant hyperthermia; requires status monitoring of liver function.

Non-drug options such as physiotherapy, targeted exercise programs, manual therapy and local modalities remain important and frequently preferred initial measures. For cost information, see the price list details page. Price guide - UK. For legal and prescribing details see United Kingdom law and open access to justice resources rights rules.

Price guide - UK

The following are approximate private prices to help with budgeting. Actual costs vary by supplier, pack size and whether a product is supplied as an unlicensed import or as a licensed UK medicine. Prices are shown in Great Britain Pounds (GBP) and are indicative as of 2026.

• Flexeril / cyclobenzaprine - not commonly licensed in the UK. If sourced as an imported or unlicensed special the private cost per tablet can be substantially higher than common generics. Indicative per-tablet range 1 to 4 GBP depending on strength, quantity and import fees; many UK pharmacies do not routinely stock it.
• Baclofen (generic) - usually inexpensive; private cost often around 0.08 to 0.30 GBP per 10 mg tablet depending on pack size.
• Tizanidine in pharmacology (generic) - roughly 0.10 to 0.35 GBP per 2 mg tablet in private supply.
• Methocarbamol (generic) - commonly between 0.10 and 0.60 GBP per 750 mg tablet when bought privately.
• Diazepam (generic) - typically low cost per tablet (a few pence for low strengths) but subject to controlled drug prescribing regulations.
• Dantrolene (generic) - generally more expensive than baclofen or tizanidine and may cost several times more per dose.

NHS prescription charges in England apply a standard charge per item (around 9.90 GBP in the year 2026. People in Scotland, Wales and Northern Ireland can obtain prescriptions at no cost. Unlicensed medicines supplied privately are commonly priced higher than NHS generics and may include extra fees for sourcing and importation.

UK legal provisions on access policy rules

• Licensing: Cyclobenzaprine is not widely licensed in the UK. A UK prescriber may still prescribe an unlicensed medicine if it is judged clinically necessary conjoined with the prescriber accepts responsibility, in line with the Human Medicines Regulations 2012 and professional mentoring and guidance.
• Prescription status: Most muscle relaxants are Prescription Only Medicines (POM). They must be prescribed by a clinician registered in the UK and supplied by a pharmacy that is registered with the General Pharmaceutical Council (GPhC).
• Online pharmacy safety: Use only UK-regulated online pharmaceutical retailers. Audit the logs supplier on the GPhC register and avoid unregulated or overseas websites that do not provide verifiable credentials.
• Personal importation: Bringing prescription medicines into the UK for personal use is controlled. Unlicensed or prescription-only medicines may be seized without the correct documentation. Controlled drugs have additional restrictions. Contact the Medicines and Healthcare products Regulatory Agency (MHRA) or ask a pharmacist for advice before importing medicines.
• Workplace safety and driving: Because the medicine can impair alertness, avoid driving or safety-critical tasks while affected. Driving when impaired by medication may be an offence.
• Use in pregnancy and children: Any use during pregnancy, breastfeeding or in children should follow a careful risk-benefit assessment and specialist advice where appropriate.

For practical advice about licensed different choices and safe routes to access medication speak with your prescriber or pharmacist. See Options contrasted and compared for commonly used options in the UK.

Important final notes

This page is intended for general information only and does not replace individual medical advice. Always adhere to the instructions given by your prescriber with the addition of the patient information leaflet that accompanies the medicine. If you develop severe symptoms or suspect a serious adverse reaction seek emergency medical help without delay.